Gilead Sciences Inc (GILD)
65.28
-1.80
(-2.68%)
USD |
NASDAQ |
Apr 25, 16:00
67.50
+2.22
(+3.39%)
After-Hours: 16:52
Gilead Sciences Gross Profit (Quarterly): 5.024B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.024B |
September 30, 2023 | 5.485B |
June 30, 2023 | 5.157B |
March 31, 2023 | 4.951B |
December 31, 2022 | 5.993B |
September 30, 2022 | 5.647B |
June 30, 2022 | 4.818B |
March 31, 2022 | 5.166B |
December 31, 2021 | 4.617B |
September 30, 2021 | 6.198B |
June 30, 2021 | 4.827B |
March 31, 2021 | 5.062B |
December 31, 2020 | 6.023B |
September 30, 2020 | 5.436B |
June 30, 2020 | 4.079B |
March 31, 2020 | 4.579B |
December 31, 2019 | 4.196B |
September 30, 2019 | 4.569B |
June 30, 2019 | 4.685B |
March 31, 2019 | 4.324B |
December 31, 2018 | 4.225B |
September 30, 2018 | 4.51B |
June 30, 2018 | 4.452B |
March 31, 2018 | 4.087B |
December 31, 2017 | 4.693B |
Date | Value |
---|---|
September 30, 2017 | 5.48B |
June 30, 2017 | 6.015B |
March 31, 2017 | 5.548B |
December 31, 2016 | 6.245B |
September 30, 2016 | 6.371B |
June 30, 2016 | 6.912B |
March 31, 2016 | 6.601B |
December 31, 2015 | 7.444B |
September 30, 2015 | 7.231B |
June 30, 2015 | 7.246B |
March 31, 2015 | 6.712B |
December 31, 2014 | 6.251B |
September 30, 2014 | 5.055B |
June 30, 2014 | 5.61B |
March 31, 2014 | 4.186B |
December 31, 2013 | 2.262B |
September 30, 2013 | 2.101B |
June 30, 2013 | 2.083B |
March 31, 2013 | 1.897B |
December 31, 2012 | 1.912B |
September 30, 2012 | 1.829B |
June 30, 2012 | 1.788B |
March 31, 2012 | 1.702B |
December 31, 2011 | 1.616B |
September 30, 2011 | 1.590B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.079B
Minimum
Jun 2020
6.198B
Maximum
Sep 2021
5.080B
Average
5.024B
Median
Dec 2023
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 5.084B |
Johnson & Johnson | 14.87B |
Eli Lilly and Co | 7.565B |
Pfizer Inc | 6.686B |
CymaBay Therapeutics Inc (DELISTED) | -- |